BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 1622436)

  • 1. Mutagenicity of the new quinolone antibacterial agent levofloxacin.
    Shimada H; Itoh S; Hattori C; Tada S; Matsuura Y
    Arzneimittelforschung; 1992 Mar; 43(3A):378-85. PubMed ID: 1622436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of new quinolone antibacterial agents on mammalian chromosomes.
    Shimada H; Itoh S
    J Toxicol Environ Health; 1996 Feb; 47(2):115-23. PubMed ID: 8598568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity study of the new cognition-enhancing agent nefiracetam.
    Shimada H; Hattori C; Tanaka N; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):251-3. PubMed ID: 8018099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute oral toxicity of the new quinolone antibacterial agent levofloxacin in mice, rats and monkeys.
    Kato M; Furuhama K; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):365-6. PubMed ID: 1622433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-six-week oral toxicity of the new quinolone antibacterial agent levofloxacin in rats and cynomolgus monkeys.
    Kato M; Furuhama K; Woolley AP; Ashby R; Fowler JS; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):367-73. PubMed ID: 1622434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of nephrotoxic effects of the new quinolone antibacterial agent levofloxacin in rabbits.
    Inage F; Kato M; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):395-7. PubMed ID: 1622439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP toxicology and carcinogenesiss studies of citral (microencapsulated) (CAS No. 5392-40-5) in F344/N rats and B6C3F1 mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2003 Jan; (505):1-268. PubMed ID: 12637974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicology and carcinogenesis studies of methylene blue trihydrate (Cas No. 7220-79-3) in F344/N rats and B6C3F1 mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 May; (540):1-224. PubMed ID: 18685714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity studies of benzalazine.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1366-8. PubMed ID: 7848359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive toxicity of the new quinolone antibacterial agent levofloxacin in rats and rabbits.
    Watanabe T; Fujikawa K; Harada S; Ohura K; Sasaki T; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):374-7. PubMed ID: 1622435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice.
    Furuhama K; Akahane K; Tawara K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phototoxic potential of the new quinolone antibacterial agent levofloxacin in mice.
    Wagai N; Yoshida M; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):404-5. PubMed ID: 1622441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the new quinolone antibacterial agent levofloxacin on multiple organ carcinogenesis initiated with wide-spectrum carcinogens in rats.
    Kajimura T; Tojo H; Kudo G; Yamada M; Domon S; Nomura M; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):390-5. PubMed ID: 1622438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and carcinogenesis studies of pyrogallol (CAS No. 87-66-1) in F344/N rats and B6C3F1/N mice (dermal studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Feb; (574):1-167. PubMed ID: 23518671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo.
    Ihsan A; Wang X; Zhang W; Tu H; Wang Y; Huang L; Iqbal Z; Cheng G; Pan Y; Liu Z; Tan Z; Zhang Y; Yuan Z
    Food Chem Toxicol; 2013 Sep; 59():207-14. PubMed ID: 23774262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the mutagenicity of 1-hydrazino-4-(3,5-dimethyl-1-pyrazolyl) pyridazino[4,5-b]indole.
    Lopez-de Cerain A; García E; Gullón A; Alvarez T; Losa MJ; Monge A
    Arzneimittelforschung; 1994 Mar; 44(3):310-2. PubMed ID: 8192696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity studies on sertaconazole.
    Romero A; Palacín C; Mosesso P; Hodson-Walker G; Marcos R; Batiste-Alentorn M; Villamayor F; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):743-5. PubMed ID: 1627196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.